If you are a deep-tech health startup dealing with the gap between a prototype and a commercial product — this project developed a Flagship structure that connects innovators with healthcare systems. This helps you reach the market faster by aligning your tech with actual patient needs.
EU Health Innovation Accelerator for Market-Ready Medical Solutions
Imagine a giant matchmaking service that connects brilliant scientists with the people who actually run hospitals and pharmacies. It helps turn a clever lab idea into a real product you can buy at a clinic. By providing training and funding, it makes sure new medical tools actually solve real patient problems instead of just staying as papers in a journal.
What needed solving
Many health innovations fail to move from the lab to the patient because of a gap between academic research and the actual needs of the healthcare market.
What was built
A unified 'Flagship' structure that integrates innovation, education, and business creation to push health products to market.
Who needs this
Who can put this to work
If you are a health-tech software provider dealing with low adoption rates in European hospitals — this project developed collaborative projects to achieve wide market uptake. It helps you integrate your digital tool into the existing healthcare economy.
If you are a biotech research firm dealing with the difficulty of scaling lab discoveries into business ventures — this project developed a support system for entrepreneurs and start-ups. It bridges the gap between your research and a sustainable health economy.
Quick answers
What is the cost or price for accessing these services?
Based on available project data, specific pricing or costs for the business plan services are not listed.
How does this project help with industrial scale?
The project focuses on accelerating needs-based innovations to achieve wide market uptake across Europe through collaborative projects and a unified Flagship structure.
What are the IP and licensing terms?
Based on available project data, specific IP or licensing frameworks are not detailed in the summary.
What is the timeline for market entry?
The current business plan operates from 2023-01-01 to 2025-12-31 to move innovations toward the market.
What kind of support is available for SMEs?
The project specifically aims to increase the value and impact of EU-based SMEs to enhance their ability to compete globally.
Who built it
The consortium is highly diverse, consisting of 14 partners across 7 countries. While it has a low industry ratio of 29% (4 companies), it leverages a massive network of 150+ partner organisations. The presence of 3 SMEs indicates a focus on scaling smaller innovators into the broader European health economy.
Contact EIT HEALTH EV in Germany for partnership opportunities.
Talk to the team behind this work.
Contact us to find the right EIT Health Flagship for your medical innovation.